After completing this course, the learner will be able to: 1) Identify at least three key findings from the analysis of Antiretroviral Pregnancy Registry (APR) data that impact clinical decision-making for HIV-positive pregnant patients. 2) Describe the four steps to report a drug exposure to the APR. 3) Identify at least two early warning signals of major teratogenicity associated with antiretroviral drug exposure. 4) Describe the importance of interprofessional collaboration in reporting to the APR.
- Provider:Centers for Disease Control and Prevention
- Activity Link: https://train.org
- Start Date: 2025-01-06 06:00:00
- End Date: 2025-01-06 06:00:00
- Credit Details: AAPA Category 1 Credit™️: 1.0 hours
AMA PRA Category 1 Credit™️: 1.0 hours
Nursing: 1.0 hours
Pharmacy: 1.0 hours - Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Performance
- Provider Ship: Jointly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest